(Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.02%182.85M | -11.22%175.85M | -19.14%172.97M | 0.09%774.78M | -3.40%185.32M | -14.44%177.49M | 1.85%198.06M | 18.63%213.92M | 28.61%774.05M | 43.45%191.84M |
Cost of revenue | -1.88%670.01M | 31.30%682.86M | ||||||||
Gross profit | 14.90%104.78M | 11.48%91.19M | ||||||||
Operating expense | 34.58%64.59M | 43.13%47.99M | ||||||||
Selling and administrative expenses | ---- | ---- | ---- | -12.74%41.88M | ---- | ---- | ---- | ---- | 43.13%47.99M | ---- |
-Selling and marketing expense | ---- | ---- | ---- | -15.15%25.75M | ---- | ---- | ---- | ---- | 77.24%30.34M | ---- |
-General and administrative expense | ---- | ---- | ---- | -8.59%16.13M | ---- | ---- | ---- | ---- | 7.54%17.65M | ---- |
Other operating expenses | ---- | ---- | ---- | --22.71M | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit | 0.84%14.27M | -32.42%11.35M | -33.53%11.6M | -6.97%40.19M | -189.82%-8.21M | 15.14%14.15M | 37.42%16.8M | 82.97%17.45M | -10.50%43.2M | 786.14%9.15M |
Net non-operating interest income (expenses) | -104.26%-5.32M | -73.09%-2.61M | ||||||||
Non-operating interest expense | -41.23%777K | -47.73%724K | -18.36%1.02M | 104.26%5.32M | 52.07%1.36M | 97.31%1.32M | 147.32%1.39M | 161.04%1.25M | 73.09%2.61M | 176.23%895K |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | -10.01%1.72M | -51.33%1.91M | ||||||||
Income before tax | 5.18%13.49M | -31.04%10.63M | -34.71%10.58M | -13.92%36.59M | -177.36%-7.86M | 10.40%12.83M | 32.15%15.42M | 78.84%16.2M | -16.14%42.5M | 119.49%10.16M |
Income tax | 30.00%3.3M | 40.46%2.62M | -29.88%2.5M | 4,475.14%8.46M | 148.15%494K | 95.84%2.54M | 481.31%1.87M | 975.68%3.56M | -95.50%185K | 73.54%-1.03M |
Net income | -0.95%10.19M | -40.89%8.01M | -36.07%8.08M | -33.54%28.12M | -174.68%-8.35M | -0.33%10.29M | 19.44%13.55M | 33.49%12.64M | -9.14%42.32M | 31.48%11.18M |
Net income continuous operations | -0.95%10.19M | -40.89%8.01M | -36.07%8.08M | -33.54%28.12M | -174.68%-8.35M | -0.33%10.29M | 19.44%13.55M | 33.49%12.64M | -9.14%42.32M | 31.48%11.18M |
Noncontrolling interests | 13.82%173K | -105.23%-9K | 3.33%372K | -837.29%-7.82M | -4,930.18%-8.5M | 850.00%152K | 149.71%172K | 207.46%360K | -82.89%-834K | 55.64%-169K |
Net income attributable to the company | -1.17%10.02M | -40.06%8.02M | -37.22%7.71M | -16.71%35.94M | -98.69%149K | -1.65%10.14M | 14.43%13.38M | 25.26%12.28M | -8.25%43.15M | 27.75%11.35M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -1.17%10.02M | -40.06%8.02M | -37.22%7.71M | -16.71%35.94M | -98.69%149K | -1.65%10.14M | 14.43%13.38M | 25.26%12.28M | -8.25%43.15M | 27.75%11.35M |
Gross dividend payment | ||||||||||
Basic earnings per share | -1.04%0.0286 | -40.31%0.0228 | -37.14%0.022 | -21.70%0.1025 | -98.82%0.0004 | -8.25%0.0289 | 7.00%0.0382 | 17.06%0.035 | -8.91%0.1309 | 24.26%0.0338 |
Diluted earnings per share | -1.04%0.0286 | -40.31%0.0228 | -37.14%0.022 | -21.70%0.1025 | -98.76%0.0004 | -8.25%0.0289 | 7.00%0.0382 | 17.06%0.035 | -8.78%0.1309 | 19.04%0.0324 |
Dividend per share | 0 | 0.00%0.025 | 0 | 100.00%0.05 | 0.025 | 0 | 0.00%0.025 | 0 | -50.00%0.025 | 0 |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data